Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Cebranopadol in Recreational Opioid Users
NCT03757559Phase 1Completed
- Sponsor
- Tris Pharma
- Start
- Apr 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cebranopadol in chronic pain (7 arms), sponsored by Tris Pharma. Primary endpoint: Drug Liking Visual Analog Scale. Started Apr 2013; status: completed.
02
Drugs
cebranopadol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03757559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03757559.